Product Description
Piperaquine phosphate is a bisquinoline antimalarial drug commonly used in combination with dihydroartemisinin (DHA-PQP) for the treatment of uncomplicated malaria, particularly for chloroquine-resistant P. falciparum. It is widely recommended by the WHO for its high efficacy and long half-life, with a 3-day treatment course often used in both treatment and mass drug administration programs